|
Issue |
Title |
|
No 8 (2025) |
Irritable bowel syndrome after acute intestinal infection: Aspects of therapy on a clinical example |
Abstract
PDF (Rus)
|
I. G. Pakhomova |
|
No 8 (2025) |
Features of changes in bone mineral density in young patients with inflammatory bowel diseases |
Abstract
PDF (Rus)
|
D. I. Abdulganieva, E. R. Myasoutova, N. G. Shamsutdinova, L. M. Kupkenova, A. Kh. Odintsova, A. Yu. Khasanshina, N. A. Cheremina, L. R. Sadykova |
|
No 8 (2025) |
Effect of antibacterial and probiotic therapy on the restoration of low fecal elastase levels in patients without imaging findings of pancreatic injuries |
Abstract
PDF (Rus)
|
Yu. A. Kucheryavyy, D. N. Andreev, N. V. Novozhilov |
|
No 8 (2025) |
Difficulty of differential diagnosis of Crohn’s disease and chronic abdominal ischemia: Case report |
Abstract
PDF (Rus)
|
D. D. Mukhametova, I. A. Kayumova, F. Emadi, A. R. Kirshina, A. Kh. Odintsova, M. S. Andreev, R. M. Nuretdinov, D. I. Abdulganieva |
|
No 8 (2025) |
Neutrophil extracellular traps in patients with ulcerative colitis |
Abstract
PDF (Rus)
|
G. R. Bikbavova, M. A. Livzan, D. G. Novikov, A. N. Zolotov, N. A. Kirichenko |
|
No 8 (2025) |
Chronic constipation: From syndrome to diagnosis and effective therapy |
Abstract
PDF (Rus)
|
O. V. Gaus, M. A. Livzan, D. A. Gavrilenko |
|
No 8 (2025) |
Efficacy of conventional treatments combined with biofeedback therapy in patients with constipation-predominant irritable bowel syndrome |
Abstract
PDF (Rus)
|
A. V. Gilyuk, D. N. Andreev, G. L. Yurenev, Yu. A. Kucheryavyy, I. V. Maev |
|
No 15 (2024) |
The problem of constipation in the practice of an outpatient doctor |
Abstract
PDF (Rus)
|
I. G. Pakhomova, A. A. Lelyakova |
|
No 15 (2024) |
Long-term efficacy and survival of ustekinumab therapy in patients with inflammatory bowel disease |
Abstract
PDF (Rus)
|
M. V. Shapina |
|
No 15 (2024) |
Frequency of detection of dyssynergic defecation in patients with overlap syndrome of functional disorders of the digestive organs associated with constipation |
Abstract
PDF (Rus)
|
I. V. Maev, A. V. Gilyuk, D. N. Andreev, A. N. Kazyulin |
|
No 15 (2024) |
Treatment of mildandmoderateforms of ulcerativecolitis: the possibilities of mesalazine |
Abstract
PDF (Rus)
|
E. Yu. Lomakina, M. V. Teberdieva, Yu. M. Buzunova, E. A. Belousova |
|
No 15 (2024) |
Important practical aspects in the management of patients with shot bowel syndrome and intestinal failure |
Abstract
PDF (Rus)
|
I. N. Leyderman |
|
No 15 (2024) |
Tofacitinib in the treatment of ulceral colitis: real-world clinical practice and prospects |
Abstract
PDF (Rus)
|
D. I. Trukhan |
|
No 8 (2024) |
Effect of ustekinumab on extraintestinal manifestations in patients with Crohn’s disease or ulcerative colitis |
Abstract
PDF (Rus)
|
D. I. Abdulganieva, D. D. Mukhametova |
|
No 8 (2024) |
Chronic constipation: current options of pathogenetic therapy |
Abstract
PDF (Rus)
|
M. D. Ardatskaya, L. I. Butorova, A. A. Anuchkin, I. N. Gaivoronsky, A. I. Pavlov, O. Yu. Patsenko |
|
No 8 (2024) |
At an appointment with a patient with diarrhea: the doctor’s algorithm of actions |
Abstract
PDF (Rus)
|
O. V. Gaus, M. A. Livzan, D. A. Gavrilenko |
|
No 18 (2023) |
Diarrhea syndrome: current aspects of differential diagnosis and treatment at the stage of primary health care |
Abstract
PDF (Rus)
|
D. I. Trukhan, E. N. Degovtsov, V. V. Goloshubina, M. A. Popilov |
|
No 18 (2023) |
Irritable bowel syndrome: modern ideas about pathology and the possibility of its correction |
Abstract
PDF (Rus)
|
S. Yu. Serebrova, D. O. Kurguzova, L. M. Krasnykh, G. F. Vasilenko, E. Yu. Demchenkova, N. N. Eremenko, E. N. Kareva, A. B. Prokofiev |
|
No 18 (2023) |
Approaches to the management of surgical patients with antibiotic-associated mild diarrhea |
Abstract
PDF (Rus)
|
D. V. Egorov, Yu. A. Lazareva, P. V. Seliverstov |
|
No 18 (2023) |
Microscopic colitis of incomplete collagen type in combination with lactase deficiency |
Abstract
PDF (Rus)
|
E. A. Volchkova, K. S. Legkova, M. D. Ardatskaya |
|
No 18 (2023) |
Abdominal pain syndrome in patients with irritable bowel syndrome: features of selection of therapy |
Abstract
PDF (Rus)
|
I. G. Pakhomova |
|
No 18 (2023) |
Is a gluten-free diet enough to treat celiac disease? |
Abstract
PDF (Rus)
|
L. S. Oreshko, Z. M. Tskhovrebova |
|
No 8 (2023) |
Irritable bowel syndrome: shifts in point of view |
Abstract
PDF (Rus)
|
О. N. Мinushkin |
|
No 8 (2023) |
Theoretical aspects of prescribing ustekinumab as first-line therapy for Crohn’s disease |
Abstract
PDF (Rus)
|
M. V. Shapina |
|
No 8 (2023) |
Functional constipation in patients with injuries of the musculoskeletal system |
Abstract
PDF (Rus)
|
Yu. A. Lazareva, D. V. Egorov, P. V. Seliverstov |
|
No 8 (2023) |
The place of antispasmodic drugs in modern therapy of irritable bowel syndrome |
Abstract
PDF (Rus)
|
K. N. Khalaidzheva, V. N. Drozdov, E. V. Shikh, S. Yu. Serebrova |
|
No 8 (2023) |
Non-invasive assessment of ulcerative colitis activity when choosing a treatment regimen |
Abstract
PDF (Rus)
|
S. I. Pimanov, E. A. Dikareva |
|
No 8 (2023) |
Nutritional correction after extensive combined bowel resections: new approaches to rehabilitation |
Abstract
PDF (Rus)
|
L. N. Kostyuchenko, A. E. Lychkova, M. V. Kostyuchenko |
|
No 15 (2022) |
Predictors of the efficacy of infliximab in patients with ulcerative colitis |
Abstract
PDF (Rus)
|
D. D. Kazarin, M. S. Chupina, A. E. Shklyaev |
|
No 15 (2022) |
Mesalazine in the induction of clinical and endoscopic remission of mild and moderate ulcerative colitis |
Abstract
PDF (Rus)
|
M. V. Shapina |
|
No 15 (2022) |
New drugs (enzymes and probiotics) in clinical practice |
Abstract
PDF (Rus)
|
О. N. Мinushkin |
|
No 15 (2022) |
Efficacy and safety of ustekinumab therapy in patients with Crohn’s disease. Real clinical practice |
Abstract
PDF (Rus)
|
O. V. Knyazev, A. V. Kagramanova, A. А. Lischinskaya, I. А. Li, E. А. Sabelnikova, A. N. Demchenko, B. А. Nanaeva, E. Yu. Zhulina, N. V. Kamzarakova, M. V. Chebotareva, N. А. Fadeeva, K. А. Nikolskaya |
|
No 15 (2022) |
Efficacy of probiotics for the treatment of irritable bowel syndrome |
Abstract
PDF (Rus)
|
V. V. Tsukanov, A. V. Vasyutin, Ju. L. Tonkikh |
|
No 15 (2021) |
Daily probiotics: benefits and reasonable application |
Abstract
PDF (Rus)
|
Yu. O. Shulpekova, V. Yu. Rusyaev |
|
No 15 (2021) |
Effectiveness of treatment of moderate ulcerative colitis with prolonged mesalazine in real clinical practice |
Abstract
PDF (Rus)
|
O. V. Knyazev, A. V. Kagramanova, A. A. Lishchinskaya |
|
No 5 (2021) |
Role of antispasmodics in the treatment of irritable bowel syndrome |
Abstract
PDF (Rus)
|
V. N. Drozdov, K. I. Arefev, S. Yu. Serebrova, I. A. Komissarenko, E. V. Shikh, A. K. Starodubtsev |
|
No 5 (2021) |
Rifaximin: unique selective antibiotic for the treatment of gastrointestinal diseases |
Abstract
PDF (Rus)
|
E. Yu. Plotnikova |
|
No 5 (2021) |
Diagnostic potential of endoscopic ultrasound for inflammatory bowel diseases and their complications |
Abstract
PDF (Rus)
|
A. A. Budzinskaya, E. A. Belousova, S. G. Tereshchenko, E. F. Akhmedova |
|
No 5 (2021) |
Evaluation of the efficacy of MMX mesalazine therapy for moderate ulcerative colitis |
Abstract
PDF (Rus)
|
O. V. Knyazev, A. V. Kagramanova, A. A. Lishchinskaya |
|
No 5 (2021) |
Comparative efficacy and safety of chimeric and recombinant anti-TNF-α mAbs |
Abstract
PDF (Rus)
|
V. N. Drozdov, E. V. Shikh, A. A. Astapovskiy, S. Yu. Serebrova, A. K. Starodubtsev |
|
No 5 (2021) |
How to improve effectiveness of treatment of patients with irritable bowel syndrome? |
Abstract
PDF (Rus)
|
E. V. Golovanova |
|
No 5 (2021) |
Patient with constipation syndrome at the ambulatory-polyclinic reception: actual aspects of differential diagnosis and treatment |
Abstract
PDF (Rus)
|
D. I. Trukhan, E. N. Degovtsov, O. V. Drokina |
|
No 15 (2020) |
Ustekinumab in patients with Crohn’s disease with extraintestinal manifestations (psoriasis) |
Abstract
PDF (Rus)
|
P. A. Makarchuk, E. Yu. Lomakina, E. A. Belousova |
|
No 15 (2020) |
Adalimumab and azathioprine in the prevention of postoperative crohn’s disease recurrence |
Abstract
PDF (Rus)
|
A. V. Poletova, M. V. Shapina |
|
No 15 (2020) |
Immunomodulatory effects of probiotics |
Abstract
PDF (Rus)
|
E. Yu. Plotnikova, Yu. V. Zakharova |
|
No 15 (2020) |
Experience of using metaprebiotics in the treatment of certain functional gastrointestinal disorders |
Abstract
PDF (Rus)
|
O. N. Minushkin, L. V. Maslovskiy, M. I. Bulanova, E. S. Gordienko, T. B. Topchiy, N. I. Beylina |
|
No 15 (2020) |
Intestine motility, secretion, and constipation treatment principles |
Abstract
PDF (Rus)
|
Yu. O. Shulpekova, V. Yu. Rusyaev, D. A. Sheptulin, N. V. Shulpekova |
|
No 5 (2020) |
A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases |
Abstract
PDF (Rus)
|
D. N. Andreev, D. T. Dicheva |
|
No 5 (2020) |
Combination of functional disorders of the digestive organs |
Abstract
PDF (Rus)
|
Y. O. Shulpekova, V. Yu. Rusyaev, D. А. Sheptulin, N. V. Shulpekova |
|
No 5 (2020) |
Skin diseases and inflammatory bowel diseases. Literature review |
Abstract
PDF (Rus)
|
T. L. Alexandrov, I. L. Khalif, A. Yu. Khalif, Z. R. Khismatullina, M. V. Shapina |
|
No 5 (2020) |
Synergism of components as the main approach to creation of a probiotic complex |
Abstract
PDF (Rus)
|
E. V. Shikh, S. A. Solovieva, A. V. Perkov |
|
No 5 (2020) |
Clinical efficacy of drugs based on probiotic strains of Saccharomyces boulardii |
Abstract
PDF (Rus)
|
V. N. Drozdov, K. I. Arefev, S. Yu. Serebrova, E. V. Shikh |
|
No 14 (2019) |
The effectiveness of mesalazine therapy of ulcerative colitis of moderate severity in real clinical practice |
Abstract
PDF (Rus)
|
O. V. Knyazev, A. V. Kagramanova, A. A. Lishchinskaya, A. I. Parfenov |
|
No 14 (2019) |
Difficult patient. Management of resistant constipation |
Abstract
PDF (Rus)
|
E. I. Sas, V. В. Grinevich |
|
No 14 (2019) |
Clinical experience with the use of the intestinal antibiotic Rifaximin for celiac disease |
Abstract
PDF (Rus)
|
L. S. Оrеshkо, E. A. Semenova |
|
No 14 (2019) |
The role of dietary fiber in the correction of digestion and constipation of various etiologies |
Abstract
PDF (Rus)
|
E. Yu. Plotnikova, T. Yu. Gracheva, M. N. Sinkovа, L. K. Isakov |
|
No 3 (2019) |
Cyclic rifaximin and soluble dietary fiber therapy for symptomatic diverticular disease: effective prevention of complications |
Abstract
PDF (Rus)
|
E. V. Golovanova |
|
No 3 (2019) |
A case of a 13-year-old patient with whipple disease |
Abstract
PDF (Rus)
|
E. V. Zhilyaev, D. T. Dicheva, D. N. Andreev, O. E. Berezutskaya, N. L. Golovkina, E. I. Kuznetsova, E. G. Prokhorova |
|
No 3 (2019) |
Optimizing the treatment of patients with irritable bowel syndrome: focus on increased compliance |
Abstract
PDF (Rus)
|
D. N. Andreev, D. T. Dicheva |
|
No 3 (2019) |
Lansoprazole in treatment of duodenal ulcer desease |
Abstract
PDF (Rus)
|
V. V. Skvortsov, O. V. Fateeva, E. M. Skvortsova |
|
No 3 (2019) |
IBS-like manifestations in large intestine diverticular disease |
Abstract
PDF (Rus)
|
V. M. Makhov, L. V. Romasenko, A. S. Panferov, Yu. A. Doronina, A. A. Balakhonov, M. V. Yurazh |
|
No 3 (2019) |
Big future for small molecule |
Abstract
PDF (Rus)
|
article Editorial |
|
No 3 (2019) |
Possibilities of sodium picosulfate application in constipation pharmacotherapy in functional intestinal disorders |
Abstract
PDF (Rus)
|
V. N. Drozdov, K. I. Karnouh, S. Y. Serebrova, I. A. Komissarenko, A. K. Starodubtsev |
|
No 3 (2018) |
Irritable bowel syndrome in view of the rome IV criteria (2016) |
Abstract
PDF (Rus)
|
D. T. Dicheva, D. N. Andreev, M. P. Scheglanova, E. V. Partsvania-Vinogradova |
|
No 3 (2018) |
New approaches to thiotropic therapy of acute intestinal infections: experience in using nifuratel |
Abstract
PDF (Rus)
|
A. A. Ploskireva |
|
No 3 (2018) |
Mineral water as non-medicamentous way in treatment of irritable bowel syndrome (IBS) |
Abstract
PDF (Rus)
|
V. V. Skvortsov, M. V. Lunkov, A. V. Kulinich, E. M. Skvortsova, A. V. Morozov, A. R. Starova, A. A. Mironov |
|
No 3 (2018) |
Innovative approach to the treatment of infections and allergies |
Abstract
PDF (Rus)
|
K. Kirillova |
|
No 15 (2017) |
USE OF 5-AMINOSALICYLIC ACID FOR TREATMENT OF ULCERATIVE COLITIS IN DIFFERENT DOSAGE MODES |
Abstract
PDF (Rus)
|
M. V. Shapina, I. L. Khalif |
|
No 15 (2017) |
PRUKALOPRIDE IN THE TREATMENT OF CHRONIC CONSTIPATION |
Abstract
PDF (Rus)
|
E. Y. Plotnikova, T. U. Gracheva |
|
No 15 (2017) |
SBBOS AND PEPTIC ULCER DISEASE: EPIDEMIOLOGY, PATHOGENESIS, INFLUENCE ON CLINICAL MANIFESTATIONS AND THERAPEUTIC APPROACHES |
Abstract
PDF (Rus)
|
O. N. Minushkin, Y. S. Skibina, T. B. Topchiy, N. V. Lvova |
|
No 15 (2017) |
ROLE OF MICROBIOTA IN HUMAN LIFE AND THE PROSPECTS FOR THE PREVENTIVE USE OF PROBIOTICS |
Abstract
PDF (Rus)
|
S. M. Zakharenko |
|
No 15 (2017) |
DIVERTICULAR DISEASE OF THE COLON: RESOLVED AND UNRESOLVED ISSUES |
Abstract
PDF (Rus)
|
M. D. Ardatskaya |
|
No 15 (2017) |
MESALAZINE PLACE IN THERAPY OF ULCERATIVE COLITIS |
Abstract
PDF (Rus)
|
I. G. Bakulin, M. I. Skalinskaya, E. V. Skazyvaeva |
|
No 15 (2017) |
HIGH QUALITY PREPARATION TO COLONOSPCOPY IS A KEY TO EXACT DIAGNOSTICS |
Abstract
PDF (Rus)
|
Y. O. Shulpekova |
|
No 14 (2016) |
Excessive bacterial growth syndrome in smal intestine up-to-date diagnostics methods and approaches to therapeutic correction |
Abstract
PDF (Rus)
|
M. D. Ardatskaya |
|
No 14 (2016) |
Drug correction of intestinal dyskinesias |
Abstract
PDF (Rus)
|
M. A. Butov, E. M. Shurpo, P. S. Kuznetsov, I. A. Zagravskaya |
|
No 14 (2016) |
Effectiveness and safety of natural mineral water rich in magnesium and sulfates for the intestinal function |
Abstract
PDF (Rus)
|
Gordana Bote, Alyaz Chokh, Annegret Auinger |
|
No 13 (2015) |
Evolution of views on the etiology, pathogenesis and treatment of irritable bowel syndrome |
Abstract
PDF (Rus)
|
G. A. Elizavetina |
|
No 13 (2015) |
Experience with Lavacol in the treatment of chronic constipation |
Abstract
PDF (Rus)
|
V. G. Kukes, E. A. Smolyarchuk, S. Y. Serebrova, D. O. Kurguzova |
|
No 13 (2015) |
Probiotics, prebiotics and metabiotics in the management of microecological bowel disorders |
Abstract
PDF (Rus)
|
M. D. Ardatskaya |
|
No 13 (2015) |
Chronic constipation (definition, epidemiology, diagnosis): current drug therapy |
Abstract
PDF (Rus)
|
O. N. Minushkin |
|
No 13 (2015) |
Bacteriophages are effective antibacterial agents in the context of global antibiotic resistance |
Abstract
PDF (Rus)
|
B. I. Aslanov |
|
No 13 (2014) |
Features of treatment of patients with constipation in irritable bowel syndrome |
Abstract
PDF (Rus)
|
Y. A. Fominykh, Y. P. Uspenskiy |
|
No 13 (2014) |
Clinico-pharmacological aspects of treatment of spastic abdominal pain |
Abstract
PDF (Rus)
|
V. I. Simanenkov, E. A. Lutaenko |
|
No 10 (2013) |
Flatulence: range of knowledge or ignorance? |
Abstract
PDF (Rus)
|
Y. O. Shulpekova |
|
No 10 (2013) |
Enterosorption: effectiveness in multimodal therapy of acute intestinal infections |
Abstract
PDF (Rus)
|
Y. V. Vasilyev |
|
No 10 (2013) |
Colorectal cancer screening |
Abstract
PDF (Rus)
|
G. I. Storozhakov, E. I. Pozharitskaya, I. G. Fyodorov |
|
No 10 (2013) |
INFLAMMATORY DISEASES OF THE COLON. CURRENT STATE OF THE PROBLEM |
Abstract
PDF (Rus)
|
V. L. Rivkin, L. L. Kapuller |
|
No 10 (2013) |
Bacteriophages: present and future aspects of use |
Abstract
PDF (Rus)
|
S. M. Zakharenko |
|
No 10 (2013) |
Chronic constipation |
Abstract
PDF (Rus)
|
V. L. Rivkin |
|
1 - 90 of 90 Items |
|